Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Cancer Genomics and Diagnostics, Advanced Proteomics Techniques and Applications, Advanced Biosensing Techniques and Applications, and RNA modifications and cancer.
Large-Scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines
Safety lead-in of the MEK inhibitor trametinib in combination with GSK2141795, an AKT inhibitor, in patients with recurrent endometrial cancer: An NRG Oncology/GOG study
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
Comprehensive Characterization of Cancer Driver Genes and Mutations
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas
Genomic and Functional Approaches to Understanding Cancer Aneuploidy
Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines
Pathogenic Germline Variants in 10,389 Adult Cancers
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers
PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness
ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics
Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers
Systematic Functional Annotation of Somatic Mutations in Cancer
Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context
Systematic Analysis of Splice-Site-Creating Mutations in Cancer
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily
Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas
Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types
Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays